Menu

Skip to content
  • Home
  • About Nina Bhardwaj MD PhD
  • Meet the Team
  • RESEARCH
    • Natural Killer cell dysfunction in human solid tumors
    • Myeloid cell-mediated resistance to immune checkpoint blockade
    • NK and T cell dysfunction in HPV-related malignancies
    • T cell responses to Tumor antigens
    • Neoantigens in Myeloproliferative neoplasms (MPN)
    • Human dendritic cell subsets in steady-state & infection
    • Harnessing the dark genome in mRNA cancer vaccination
    • Leveraging cDC1 populations for enhanced RNA cancer vaccination- Ross Ward
  • RECENT PUBLICATIONS 
  • Contact
THE BHARDWAJ LAB
  • Home
  • About Nina Bhardwaj MD PhD
  • Meet the Team
  • RESEARCH
  • RECENT PUBLICATIONS 
  • Contact

Menu

Skip to content
  • Home
  • About Nina Bhardwaj MD PhD
  • Meet the Team
  • RESEARCH
    • Natural Killer cell dysfunction in human solid tumors
    • Myeloid cell-mediated resistance to immune checkpoint blockade
    • NK and T cell dysfunction in HPV-related malignancies
    • T cell responses to Tumor antigens
    • Neoantigens in Myeloproliferative neoplasms (MPN)
    • Human dendritic cell subsets in steady-state & infection
    • Harnessing the dark genome in mRNA cancer vaccination
    • Leveraging cDC1 populations for enhanced RNA cancer vaccination- Ross Ward
  • RECENT PUBLICATIONS 
  • Contact

Welcome to the Bhardwaj Laboratory

The Bhardwaj Lab studies T cells, NK cells, Macrophages, and Dendritic Cells in the context of tumor immunotherapy

BlueSky @bhardwajlab.bsky.social

  • ACIR featured article –  December 2020
  • Focus of the laboratory

Contact Us

Bhardwaj Laboratory
Tisch Cancer Institute
New York, NY 10029.
Email: bhardwajlaboratory@mssm.edu

Twitter

Available Positions